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Abstract
Toxoplasma gondii (T. gondii) causes toxoplasmic encephalitis resulting from 
reactivation of latent toxoplasmosis. It is the most frequent clinical manifestation, 
characterized by multiple necrotizing brain lesions. Bradyzoite tissue cysts activate 
an immune response that has a major impact on controlling parasite persistence in 
the brain. The immune mechanisms stimulated in the brain cause a local inflam-
matory mediated by Th1 immune reaction cytokines. Several studies have linked 
this process to that active during different neuropsychiatric disorders, such as 
Schizophrenia. In addition to the immune reaction activated in the brain, this 
latter has the capacity to stimulate neurotransmitter production. T. gondii induces 
high concentrations of dopamine and tyrosine hydroxylase in the central nervous 
system and has also been shown to increase kynurenine/tryptophan ratio and 
elevated Kynurenic acid level, mainly in astrocyte cells. This imbalance plays a role 
in the pathophysiology of Schizophrenia. Results of different studies explain in this 
chapter support the idea that Toxoplasma is an etiological factor in Schizophrenia.
Keywords: Toxoplasma gondii, neuropsychiatric disorders, schizophrenia, immunity, 
neurotransmitter
1. Introduction
Toxoplasmosis is one of the most common parasitic zoonosis in the world. Its 
causative agent, Toxoplasma gondii, is an obligate intracellular protozoan, which 
has developed several potential pathways for the transmission between different 
host species. T. gondii is able to establish a persistent infection within the brain. 
In this case, the immunocompetent subject will harbor latent Toxoplasma cysts in 
his central nervous system (CNS). Chronic Toxoplasma infection is asymptomatic 
although studies suggest that it may be a factor associated with chronic neurologi-
cal conditions (Schizophrenia, Parkinson, bipolar diseases, etc.) [1, 2]. When the 
infection occurs in a pregnant woman, contamination of the fetus is possible with 
varying consequences depending on the stage of embryogenesis and the degree 
of maturity of the immune system. The neurological disorders (hydrocephalus, 
microcephaly, mental retardation, intracranial calcification) or ocular (retino-
choroiditis) of congenital toxoplasmosis reflect the neurological tropism of this 
parasite [3]. Similarly, during a progressive degradation of the immune system 
functions following infection with the human immunodeficiency virus (HIV) or 
immunosuppressive treatment, the brain is the preferred target for the reactivation 
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of latent Toxoplasma cysts [4, 5]. Parasite multiplication in the CNS induces a local 
inflammatory reaction resulting in brain damage and a strong synthesis of neu-
rotransmitters which are involved in necrotizing brain lesions and in neurological 
disorders. The relationship between T. gondii infection and the development of the 
bipolar disorder (BD) has long been investigated, Evidence studies suggest that this 
infection may be related to neuropsychiatric disorders, especially Schizophrenia. 
Immune response has a major role in the persistence of T. gondii cysts in the brain. 
The protective immune reaction against Toxoplasma is very complex. During pri-
mary infection, the components of the nonspecific immune response occur first. T. 
gondii tachyzoites reach the intestinal lumen, enter the intestinal cells, and multiply 
in the cells of the lamina propria [6]. At this stage, infected enterocytes activate 
an immune response to limit parasite multiplication [7]. This response mainly 
involves neutrophils, macrophages, monocytes and dendritic cells via the secretion 
of different chemoattractant proteins. Secondarily, cellular immune response is 
specifically activated against the parasite [8]. It is essentially an immune response 
Th1-type. This response is marked by interleukin (IL)-12 production by antigen 
presenting cells, and interferon-gamma (IFN-γ) production by CD4+ T cells, CD8+ 
T cells, and natural killer (NK) cells (Figure 1). The Th1-type reaction most often 
induces a local inflammatory reaction, hence the interest of activating a Th2-type 
immune reaction that inhibits the activation of the Th1 immune response. The Th2 
response is mediated primarily by two interleukins IL-4 and IL-10 [6] (Figure 1). 
This immune regulation seems to be of great interest in reducing the inflammatory 
reactions responsible for most lesions, but it makes the soil favorable to parasite 
multiplication. Despite the immune responses against T. gondii, this parasite has the 
ability to escape and spread via the bloodstream to infect different organs. In the 
central nervous system, tachyzoites have the ability to cross the blood-brain barrier 
(BBB), infect different types of nerve cells, and become encysted bradyzoites that 
persist throughout the life of the host. Several studies have shown in the mouse 
model the importance of IFN-γ in this control [9]. Among the parasitic factors, the 
genotype also has a role in the influence of the evolution of Toxoplasma infection. 
Type I strains are associated with high virulence in mice, whereas type II or III 
strains are considered avirulent for mice. Type I tachyzoites have the ability to cross 
epithelial barriers and reach immune-privileged sites more rapidly than type II 
Figure 1. 
Diagram showing the cerebral immune response during a cerebral toxoplasmosis infection in mice.
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strains [10]. In human, several studies have reported severe acquired toxoplasmosis 
due to atypical strains in immunocompetent individuals. An overrepresentation 
of other atypical strains has been observed in patients with ocular toxoplasmosis 
[11]. The influence of the parasite strain on the development of the infection or the 
cerebral pathology remains however unknown.
2. The cerebral anti-Toxoplasma immune reaction
2.1 The central nervous system immunity
The central nervous system is closely linked to the immune system at several levels. 
The cerebral parenchyma is separated from the periphery by the BBB, the integrity 
of which is maintained by tight endothelial junctions. This barrier under normal 
conditions prevents the entry of mediators such as activated leukocytes, antibodies, 
complement factors, and cytokines. The myeloid cell line plays a crucial role in the 
development of immune responses at the central level, it includes two main subtypes: 
microglial cells, distributed in the cerebral parenchyma; perivascular macrophages 
located in the capillaries of the basal lamina brain and the choroid plexus. In addi-
tion, astrocytes, oligodendrocytes, endothelial cells, and neurons are also involved 
in the immune response in the CNS. By modulating synaptogenesis, microglial cells 
are more particularly involved in the restoration of neuronal connectivity following 
inflammation. These cells release immune mediators, such as cytokines, that modulate 
synaptic transmission and alter the morphology of dendritic spines during the inflam-
matory process after injury. Thus, the expression and release of immune mediators 
in the cerebral parenchyma are closely related to the plastic morphophysiological 
changes in the dendritic spines of neurons. Based on these data, it has been proposed 
that these immune mediators are also involved in the learning and memory processes. 
Microvasculature is a key element of brain damage. Endothelial cells are an important 
source of immune mediators such as a nitric oxide (NO), which are involved in the 
process of immune cell adhesion [12, 13]. A recent study shows that T. gondii invasion 
of neural tissue is mediated by epidermal growth factor receptor (EGFR), enhancing 
invasion likely by promoting survival of the parasite within endothelial cells [14]. 
Damage to the BBB can lead to increased permeability, which facilitates leucocyte 
access to the brain parenchyma. The release of mediators of endogenous inflamma-
tion and neurotoxins and the promotion of phagocytosis of cellular debris [6, 14]. 
Excessively activated microglial cells can cause major histocompatibility complex 
class II (MHCII) expression. This molecule facilitates the involvement of these cells 
in immune responses. Activation of microglial cells strongly influences the profile of 
cytokines released by two distinct mechanisms: recognition receptors and activation 
of the immune response [13, 15]. Activation of monocytes and macrophages is an 
important part of the innate immune response; it induces the production of pro-
inflammatory cytokines and chemokines such as IL-8, monocyte chemoattractant pro-
tein1 (MCP-1), macrophage inflammatory proteins (MIP-1α and MIP-1β). Regulatory 
cytokines can also be activated within the CNS, such as IL-4 and IL-10 [8]. Expression 
of MHCII and adhesion molecules (CD11a, CD40, CD54, CD80, CD86) in activated 
microglial cells indicates that these cells can acquire antigen presenting activity and 
participate in the activation of T cells [16]. This suggests the existence of a network 
of complex interactions linking microglial cells, astrocytes and T cells; which creates 
a balance between the Th1/Th2 signals, which defines the immune response of the 
CNS. The role of astrocytes in the CNS is even more complex than that of microglial 
cells. Astrocytes are divided into two main subtypes: fibrous astrocytes located in the 
white matter; protoplasmic astrocytes located in the gray matter. These contribute to 
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the formation of the BBB [6, 15]. Astrocytes also act as neuroprotectants by secreting 
neurotrophic and releasing potentially toxic pro-inflammatory molecules.
2.2 The mechanism of T. gondii invasion in the brain
In the brain, dendritic cells and monocytes are the most permissive cells for 
initial Toxoplasma infection [17]. These cell populations probably play an important 
role in the spread of the parasite, including in the brain. The CD11c+ CD11b− den-
dritic cells infected promote the diffusion of T. gondii of the lamina propria to the 
mesenteric lymph nodes. Monocytes CD11c+ CD11b− are the main cell population 
that contains tachyzoites in the blood [17]. T. gondii was detected in mononuclear 
cells + of infected mice 1 day after receiving an intravenous injection of CD11b+ 
cells [18, 19].
The transepithelial migration capacity of tachyzoites is implicated in the passage 
of the parasite across the BBB. This could be done through the interaction of the 
intercellular adhesion molecule 1 (ICAM-1) of the BBB cells with the parasite MIC2 
protein [20]. This interaction is important for transmigration of tachyzoites, as 
demonstrated in vitro in monolayers of several different cell lines [20] (Figure 1).
Macrophages are also responsible for the spread of T. gondii in the brain [21, 22]. 
The migration of infected macrophages into the CNS is mediated by the uPA/uPAR 
pathway and the expression of metalloproteinases 9 (MMP9) [23]. In the mouse 
brain during the acute phase of infection, T. gondii tachyzoites are able to infect all 
brain cells, mainly microglial cells, astrocytes and neurons. However, microglial 
cells tend to react against the parasite. These cells inhibit the growth of T. gondii and 
can, therefore, function as important inhibitors of T. gondii propagation in the CNS 
by mechanisms independent of NO and IFN-γ; but this does not prevent T. gondii 
from being able to encyst in these cells [15, 24]. Astrocytes and rat neurons are also 
suitable to host cells for the intracerebral proliferation of the PLK (type II) T. gondii 
strain [24]. These cells can harbor tachyzoites and cysts during the two respective 
phases of Toxoplasma infection [25]. Astrocytes also have the ability to control the 
proliferation of tachyzoites during the acute phase of infection for the local control 
of this opportunistic pathogen [26]. In neurons, the presence of tachyzoites or 
bradyzoites alters the functioning of infected neurons. These modifications will 
favor the persistence of the parasite [27, 28].
2.3 The regulation of the cerebral immune mechanism during T. gondii infection
After T. gondii has entered the CNS through the BBB, a cerebral immune 
response is triggered against the parasite. Experimental data on animal models 
show that the Th1-type immune response is activated against T. gondii to control 
the replication of the parasite in the brain. In the murine model, this immune 
response leads to the production of IFN-γ after infection with the ME49 (type II)  
strain [29–31]. This cytokine is the main mediator of parasite resistance in the 
murine model. IFN-γ produced by brain-resident cells is crucial for facilitating 
both the protective innate and T cell-mediated immune responses to control 
cerebral infection with T. gondii. Mice deficient for the IFN-γ receptor or those 
that are neutralized by an anti-IFN-γ antibody, are unable to control acute 
Toxoplasma infection [32]. During this host response, other cytokines and 
chemokines are produced. These may promote the infiltration of immune cells 
to the site of infection [33]. T cells and IFN-γ are essential for maintaining the 
latency of chronic infection in the brain and the prevention of reactivation of 
latent infection. The protective activity of T lymphocytes (CD4+, CD8+) results 
in the production of IFN-γ (Figure 1). The protective activity of these cells has 
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been demonstrated in a transfer of immune cells T, which conferred protection 
against the reactivation of cerebral toxoplasmosis in an IFN-γ deficient mouse 
[34]. However, the presence of TCD4 and TCD8 cells appears to be critical for 
the long-term maintenance of the latency of chronic Toxoplasma infection in 
the brain. In addition, mRNA encoding IFN-γ was also detected in the brains of 
T. gondii-infected and NK-cell deficient mice. This suggests that IFN-γ could be 
produced by non-T cells and non-NK cells. This production is important for the 
maintenance of chronic toxoplasmosis in the brains of mice [35]. Microglial cells 
and macrophages are identified as the major non-T and non-NK cells that express 
IFN-γ in the brains of T. gondii-infected mice [36]. Therefore, it is possible that 
the production of IFN-γ by these cells plays an important role in the prevention 
of cerebral toxoplasmosis. Microglial cells play an important role on the one hand 
in the innate defense system that limits parasite proliferation and on the other 
hand by regulating the production of chemokines that facilitate the accumula-
tion of T lymphocytes at the parasite multiplication site. Murine astrocytes 
have also been implicated in inhibiting the growth of type II T. gondii strain 
in vitro. Astrocytes infected with ME49 (type II) Toxoplasma strain, produce 
IL-1, IL-6 and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) 
[37]. During the innate immune response, dendritic cells, macrophages, and 
neutrophils produce IL-12 in response to T. gondii infection. This cytokine is 
essential for the production of IFN-γ. Neutralization of IL-12 with antibodies to 
this cytokine resulted in 100% mortality in mice infected with an avirulent strain 
of T. gondii, mortality was associated with decreased production of IFN-γ [38]. 
In addition, IL-12 is also important for maintaining IFN-γ production by T cells 
during chronic infection. The production of IL-12 is regulated by Lipoxin A4 
(LXA4), in order to avoid pathogenic inflammatory reactions in the brain during 
the chronic phase of T. gondii infection. This has been demonstrated by the high 
production of LXA4 in the serum of mice during chronic Toxoplasma infection 
5-Lipoxygenase (5-LO) is an essential enzyme in the production of LXA4, 5-LO 
deficient mice succumbed to infection during the chronic phase, thus presenting 
a cerebral inflammatory reaction [39]. LXA4 is important for the downregulation 
of pro-inflammatory responses during the chronic phase of T. gondii infection. 
Studies have shown that lipoxins activate two receptors (AhR and LXAR) in den-
dritic cells. This activation triggers the expression of the suppressor of cytokine 
signaling (SOCS)-2. SOCS-2 deficient mice succumb to chronic T. gondii infec-
tion. This is accompanied by a strong production of IL-12, IFN-γ, and reduction 
of cerebral cysts [40]. Although Th1 immune responses play a critical role in 
resistance to T. gondii infection, Th2-like immune responses are also implicated 
in protective immunity. IL-4 plays a major role in the development of the cellular 
immune response and in the differentiation of T cells into Th2 cells. During the 
chronic phase of Toxoplasma infection, IL-4 inhibits the production of pro-
inflammatory mediators to prevent the development of local inflammations, 
promoting the persistence of cysts in the brain. Mice deficient in IL-4 die during 
the late phase of infection [41]. In these mice, a histological study reveals local 
areas of acute inflammation associated with the multiplication of tachyzoites in 
the brain. These results indicate that IL-4 is protective against the development 
of toxoplasmic encephalitis by preventing the formation of cysts and the prolif-
eration of tachyzoites in the brain. The action of IL-4 during the chronic phase of 
infection is enhanced by the production of IL-10 by T cells [41]. IL-10 also exerts 
an immunomodulatory role in regulating the Th1-type inflammatory immune 
response [42]. Mice deficient in IL-10 and treated with sulfadiazine develop 
fatal inflammatory responses in the brain during the late stage of infection [43]. 
IL-10 is important for the survival of mice during the acute and chronic phases 
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of infection. This is confirmed by the neutralization of this cytokine in T. gondii-
infected mice [44] and following vaccination of the mice with T. gondii antigens 
(E/SA) [45].
3. The role of T. gondii in the etiopathogenetic of psychiatric diseases
Any infectious agent can affect neurons and brain structures after activation of 
the proinflammatory immune response and neurotransmitters, thus causing psy-
chosis. Among the different infectious agents, T. gondii has received more attention 
for its location in the CNS. Many studies have suggested that toxoplasmosis is a risk 
factor for the development of behavioral changes and neuropsychiatric disorders 
such as depression, Schizophrenia, Alzheimer and Parkinson diseases. During 
an acute infection, the parasite is mainly present in peripheral tissues and blood, 
but also has access to the brain via immune circulating cells, as is explained in the 
part of Regulation of the cerebral immune mechanism during T. gondii infection. An 
early feature of T. gondii brain infection is the activation of glial cells, particularly 
astrocytes and microglia [24, 25, 46]. Toxoplasma cysts reside in the brain during 
latent infection. In individuals with acquired immune deficiencies, e.g., AIDS, or 
undergoing prolonged immunity, suppressive treatments, reactivation of the infec-
tion can lead to toxoplasmic encephalitis, also calling for cerebral toxoplasmosis. In 
recent years it has been shown that the latent toxoplasmosis, although often rejected 
as asymptomatic and clinically unimportant, can modify host behavior in human 
and rodents. This parasite has the capacity to be an etiological factor for some 
neuropsychiatric diseases [47].
A bunch of data hypothesizes that latent toxoplasmosis may be a risk factor for 
the depression. The low-grade inflammation caused by the chronic Toxoplasma 
infection it could be related to the development of behavioral symptoms, but the 
results have been varied multifactorial [48]. Regarding, the possible relation-
ship between Toxoplasma infection and depression, study shows that specific 
Toxoplasma IgG titer levels correlated positively with depression [49]. One study 
found that this infection affected susceptibility to depression and severity of 
depressive symptoms in pregnant women [50]. Another study showed that male 
subjects infected with Bartonella henselae displayed more severe depressive symp-
toms when co-infected with T. gondii [51] but Pearce and collaborators, Sutterland 
and collaborators concluded that there is not any relationship between T. gondii 
infection and depression [52, 53]. Psychiatric patients with primarily severe or very 
severe depression are displaying more severe symptoms when are infected with T. 
gondii. In this recent study, results suggest that Toxoplasma infection can be related 
to anxiety, burnout and potentially to the severity of depression [48]. The possible 
link between T. gondii infection and Parkinson diseases is controversial. Tissue cysts 
of T. gondii reside especially in the amygdala, olfactory bulbs, hippocampus, cortical 
regions, and hypothalamus and could actively inhibit neuronal function in chroni-
cally infected mice [54]. Tachyzoite infection of neurons resulted in a dysregulated 
Ca2+ influx upon stimulation with glutamate, the major excitatory amino acid in 
the CNS leading either too hyper- or hypo-responsive neurons. Other experiments 
indicate that tachyzoites deplete Ca2+ stores in the endoplasmic reticulum that may 
contribute to the altered behavior of the host [54]. In addition, alteration of neu-
rotransmitter pathways, degradation of dopamine-producing nerve cells and neuro-
genic inflammation induced by T. gondii infection are mentioned as etiology that 
could eventually lead to Parkinson disease [55]. Regarding the effect of Toxoplasma 
on the production of dopamine (DOPA) in the brain, studies have shown that this 
parasite-induced high concentrations of DOPA and tyrosine hydroxylase (TH) 
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in CNS [56]. Parkinson disease is associated with lower levels of DOPA. So, the 
association between Toxoplasma infection and neuropsychiatric disorders could be 
strongly related to Schizophrenia but not Parkinson’s disease [57]. Evidence suggests 
that T. gondii could be an etiological factor for Schizophrenia. Clinically, latent toxo-
plasmosis and Schizophrenia both induce similar alteration in brain morphology: 
gray matter atrophy, loss of brain parenchyma, ventricle system enlargement, CD4+ 
and CD8+ T cell influx, pro-inflammatory immune system infiltration, dendritic 
retraction in basolateral amygdala accompanied by reduced corticosterone secre-
tion, which may deal with T. gondii-induced behavioral change [47, 58, 59]. Indeed, 
the relationship between chronic or acute Toxoplasma infection and Schizophrenia 
seems to exist. Researches in this field are increasing to determine the existence of 
this association by epidemiological, medical and biological studies. The following 
section presents an overview of the explanations published.
3.1  The cerebral immune response activated during schizophrenia  
and T. gondii infection
In cerebral toxoplasmosis, the balance between host immunity and defense 
mechanisms in the event of parasite escape is the basis of asymptomatic infec-
tion. Inflammation and immune deregulation have consistently been observed 
in both Toxoplasma infection and Schizophrenia. In the acute phase of infection, 
Th1 proinflammatory reaction is promoted by cytokines released in CNS to 
control parasite multiplication, this reaction was controlled by activation of Th2 
immune reaction to minimize local cerebral inflammation. This immune response 
enhances the multiplication of parasite and promotes persistence of Toxoplasma 
tissue cysts in neuronal and glial cells. In Schizophrenia, an imbalance Th1 and 
Th2 reaction have shown with major activation of Th2 immune response and 
production of IL-6 and IL-10 [60]. IFN-γ, IL-12, TNF-α, IL-4 and IL-10, together 
with IL-1 and IL-1β, IL-2, IL-6, granulocytes (GM-CSF and GSF), IL-17 and IL-23 
are variably expressed by astrocytes, microglial cells, neuron, TCD4+ and TCD8+ 
cells [9, 13,  31, 41–43] (Figure 1). All these immune mediators have shown to be 
markers for acute exacerbations of Schizophrenia [60]. This immune system can 
influence mood and behavior through their ability to modulate neurotransmis-
sion; therefore, the idea that latent infection is clinically asymptomatic may be 
associated with neuropsychiatric disorders. Since tachyzoites induce inflamma-
tory tropism in host cells more than bradyzoites, the proliferation of tachyzoites 
in the brain after cyst rupture may be related to the onset of Schizophrenia and 
other mental illnesses [61]. In people with acute Schizophrenia, the display of 
symptoms has increased responses to cytokines. With regard to cytokine-induced 
effects, the role of IL-1β and IFN-γ in the activation of astrocytes have a major 
role. These immune proteins induce activation of astrocytes and microglia cells to 
inhibit tachyzoite replication by producing high levels of NO. In addition, experi-
mental studies in rodents have shown that TCD8+ cells play a central role in long-
term immunity to Toxoplasma. Depletion of CD8+ T cells may cause reactivation 
of latent disease in later phases of chronic toxoplasmosis. Interest in the potential 
correlation to this observation is the regulation of TCD8+ lymphocytes typically 
observed in schizophrenic patients [62]. After a short acute toxoplasmosis phase, 
the infection becomes latent and becomes encysted in the central nervous system 
and muscle tissue, probably throughout the life of the infected host. Evidence 
suggests that the parasite affects the synthesis of neurotransmitters, particularly 
DOPA, in infected individuals, which could lead to neurological and psychiatric 
disorders [63]. In addition to the studies that directly indicated the association 
between Toxoplasma infection and the increased incidence of Schizophrenia, 
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some indirect evidence also highlighted the role of T. gondii in the etiology of 
Schizophrenia. More knowledge about the pathogenesis of the disorder would 
lead to more effective prevention and treatment strategies.
3.2  The neurobiological studies related to T. gondii infection to schizophrenia 
disease
There are differences in T. gondii infection; the acute phase and the chronic and 
phase. Cerebral cysts are formed in the cerebral hemispheres, hippocampus, amyg-
dala, basal ganglia, cerebellum, cerebral cortex, brainstem, and olfactory bulb, and a 
variety of brain cells that may be infected, including neurons, microglia and mainly 
astrocytes [46] (Figure 1). Encysted T. gondii bradyzoites are capable of inhibiting 
apoptosis and modulates some signaling pathways such as nuclear factor (NF-𝜅B), 
mitogen-activated protein kinase (MAPKinase), phosphoinositide 3 kinase (PI3K)/
PKB/Akt and c-Jun N-terminal kinases (JNK); so that they can persist in host cells 
for long periods of time [64]. As cysts develop, the host cell degenerates and can 
break, releasing bradyzoites that can differentiate into tachyzoites, invade and kill 
surrounding cells, if uncontrolled by the immune system. Especially in immunocom-
promised patients, the infection is severe, sometimes with hydrocephalus, acute nec-
rotizing encephalitis, and glial nodules formation. Lesions in the brain can manifest 
as behavioral symptoms by interfering with brain function in the area surrounding 
the lesion via mass effects or paracrine secretions. This explains the observation of 
high-concentration tissue cysts in the amygdala and nucleus accumbens, containing 
dopamine in limbic regions of the brain known to be an important control of motiva-
tion, pleasure, dependence, reward, and fear [47]. Other effects are more intriguing; 
Alteration of the neurotransmitter involves the production of homologous proteins 
to aromatic amino acid TH and dopamine (DOPA) 2 receptor (D2R) compounds 
with an increase in DOPA synthesis, tryptophan (TRP) degradation and the decrease 
in serotonin synthesis [56, 65].
The most likely mechanism of action in Schizophrenia affects neurotrans-
mission in specific brain areas such as the thalamic-cortical limbic circuit of 
DOPA, 5-hydroxytryptamine (5-HT), gamma-aminobutyric acid (GABA), and 
glutamate. As a result, schizophrenic patients show abnormal levels of these 
neurotransmitters. Studies show an increase in DOPA release in the limbic system 
[47, 66]. In addition, T. gondii involves in the etiopathogenesis of Schizophrenia 
affecting neurotransmitters, especially DOPA [67]. The production T. gondii 
bradyzoites leads to induce liberation of TH, the enzyme that catalyzes the 
conversion of L-tyrosine (L-Tyr) to L-dihydroxyphenylalanine (L-DOPA) [68] 
and then L-DOPA is converted to DOPA by the enzyme DOPA decarboxylase. 
Dopamine is shown to be an essential product that stimulates proliferation and 
enhance infection and conversion of T. gondii in the brain [68]. After the synthe-
sis of DOPA, it is transformed into phenylalanine (Phe) and tyrosine (Tyr) via 
the activity of phenylalanine hydroxylase (PAH). the elevation of the Phe/Tyr 
ratio and the alteration of PAH activity is related to the activation of the Th1-type 
immune response, which is activated during T. gondii infection. The increase 
in DOPA production was originally thought to be a product of inflammation of 
brain tissue (Figure 2). Blood levels of Phe and Tyr were increased in T. gondii-
positive individuals with aggressive personality traits, and in particular those 
with overt history of aggression and suicidal behavior, so this mechanism could 
explain the link between Toxoplasmosis and Schizophrenia [69]. The increased 
concentration of DOPA in specific parts of the brain of patients is presumed to be 
responsible for the positive symptoms of this mental disorder. However, studies 
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have identified two genes for limiting the TH synthesis in the genome of T. gondii; 
these genes expressed in the brain are responsible for DOPA overproduction 
in T. gondii tissue cysts that is responsible for the positive symptoms of some 
Schizophrenia patients [70].
In addition to DOPA, studies have also evaluated alterations of the kynuren-
ine pathway (KYN) and involvement of TRP [71, 72]. In immunocompetent 
hosts, infection with T. gondii leads to the production of IFN-γ and production 
of indoleamine 2,3-dioxygenase (IDO), which converts the TRP to KYN and 
inhibits T. gondii growth. The metabolism of Tryptophan generates kynurenine 
and 3-hydroxykynurenine. The imbalance of these catabolites plays a role in the 
pathophysiology of Schizophrenia with positive and negative symptoms, which 
are reversible in response to antipsychotic treatment impact on such imbalance 
[71]. Additionally, alterations of the KYN pathway have also been shown with 
an increased KYN/TRP ratio and elevated kynurenic acid (KYNA) levels [73]. 
Activation of the KYN pathway following T. gondii infection may be part of a 
biological defense strategy against T. gondii infections. In the brain, this metabolism 
pathway takes place mainly in astrocytes that release newly produced KYNA into 
the extracellular environment, where it can influence surrounding neurons. KYNA 
synthesis is initiated also by tryptophan dioxygenase (TDO), this enzyme has 
shown that is elevated in the brains of Schizophrenia patients particularly in astro-
cytes and glial cells [74]. T. gondii infection in the CNS is accompanied, in response 
to parasite invasion or an inflammatory reaction, by strong activation of astrocytes 
and glial cells, resulting from high KYNA synthesis in these stimulated cells [75]. 
This reaction promotes high production of TDO or IDO in the brain and enhances 
proinflammatory cytokine expression in the site of T. gondii infection. These neuro-
biological data relating Toxoplasma infection to neuropsychiatric diseases.
Figure 2. 
Diagram showing the neurobiological pathway related to T. gondii infection to schizophrenia disease.
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4. Conclusion
The question that Toxoplasma infection could be the etiological cause psychologi-
cal diseases and behavioral disorders is still under study. Recent studies try to prove 
this relationship. Study of Lindgren and collaborators demonstrated a significant 
association between T. gondii seropositivity and psychotic symptoms [76]. Vlatkovic 
and collaborators find an increased prevalence of T. gondii infection in a patient with 
Schizophrenia [77]. So, increased risk of developing toxoplasmosis infection prior to 
the onset of Schizophrenia was reported in several epidemiological, neurobiological 
and parasitological studies. One day this association will be a new method of diagno-
sis, treatment, and prevention of development of Schizophrenia. Therefore, health 
education on personal and nutritional hygiene given to patients and healthy people, 
especially early age, can help reduce the risk of contact with infectious agents and 
subsequently could decrease the incidence of behavior disorders.
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